AI handles the grind while your people drive impact.
Optimize Efficiency. Unleash Potential.
The AI Portfolio Optimizer
Algorithmic portfolio optimization, not political compromise.


THE PROBLEM:
You're staring at 25 projects requesting $450M when you have $300M. Your team has 520 FTEs but projects demand 840. Every program head insists their project is critical. Leadership wants maximum risk-adjusted returns while the CFO demands cuts. Portfolio meetings become political battles where the most persuasive advocates win, not necessarily the best projects. You know there's an optimal combination that maximizes value, but you're trapped in spreadsheet paralysis. You need algorithms, not arguments.
WHAT OPTIMIZER DELIVERS:
THE OUTCOME:
Portfolio decisions backed by optimization algorithms, not political horse-trading. Your leadership team evaluates 5 scientifically optimal scenarios—each maximizing different objectives (max NPV, max diversification, balanced risk-return). You see which projects make the cut under different constraints and why. Resource allocation becomes defensible with data—"here's why this combination maximizes value." Political pressure gives way to optimization intelligence.
WHO OPTIMIZER HELPS:
Portfolio VPs managing resource-constrained portfolios who need optimization intelligence to maximize risk-adjusted value—not political compromise.
Prompt:
Optimize three-asset GLP-1 portfolio under $2.5B budget constraint. Generate five scenarios maximizing different objectives—competitive speed, risk minimization, balanced execution, mechanism diversification, and recommended configuration. Compare budget utilization, timeline to approval, resource contention, Year 3 revenue, and strategic flexibility across scenarios with key trade-off analysis.

Prompt:
Analyze portfolio resource contention for three-asset GLP-1 metabolic portfolio across clinical operations, regulatory affairs, biometrics, manufacturing CMC, and quality systems by quarter. Identify critical contention periods during 2025-2026 regulatory engagement, function-specific bottlenecks, and relief windows. Provide strategic recommendations for capacity planning including CRO partnerships and CDMO network establishment.

Prompt:
Visualize portfolio timeline synchronization for three-asset GLP-1 metabolic program showing clinical completion, regulatory dossier, manufacturing scale-up, and FDA review phases across oral GLP-1 agonist, GLP-1/glucagon dual agonist, and GLP-1/amylin dual agonist. Provide recommended scenario with competitive launch timing, strategic sequencing rationale, and three immediate actions with investment allocation.

Unipr is built on trust, privacy, and enterprise-grade compliance. We never train our models on your data.






Start Building Today
Log in or create a free account to scope, build, map, compare, and enrich your projects with Planner.